Literature DB >> 28634831

Malaria 2017: Update on the Clinical Literature and Management.

Johanna P Daily1.   

Abstract

PURPOSE OF REVIEW: Malaria is a prevalent disease in travelers to and residents of malaria-endemic regions. Health care workers in both endemic and non-endemic settings should be familiar with the latest evidence for the diagnosis, management and prevention of malaria. This article will discuss the recent malaria epidemiologic and medical literature to review the progress, challenges, and optimal management of malaria. RECENT
FINDINGS: There has been a marked decrease in malaria-related global morbidity and mortality secondary to malaria control programs over the last few decades. This exciting progress is tempered by continued levels of high transmission in some regions, the emergence of artemisinin-resistant Plasmodium falciparum malaria in Southeast Asia, and the lack of a highly protective malaria vaccine. In the United States (US), the number of travelers returning with malaria infection has increased over the past few decades. Thus, US health care workers need to maintain expertise in the diagnosis and treatment of this infection. The best practices for treatment and prevention of malaria need to be continually updated based on emerging data. Here, we present an update on the recent literature on malaria epidemiology, drug resistance, severe disease, and prevention strategies.

Entities:  

Keywords:  Drug resistance in malaria; Malaria control; Malaria epidemiology; Malaria treatment; Post-artemisinin delayed hemolysis; Severe malaria

Year:  2017        PMID: 28634831     DOI: 10.1007/s11908-017-0583-8

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  27 in total

Review 1.  Update on Malaria Diagnostics and Test Utilization.

Authors:  Blaine A Mathison; Bobbi S Pritt
Journal:  J Clin Microbiol       Date:  2017-04-12       Impact factor: 5.948

2.  Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial.

Authors:  Meghna Desai; Julie Gutman; Anne L'lanziva; Kephas Otieno; Elizabeth Juma; Simon Kariuki; Peter Ouma; Vincent Were; Kayla Laserson; Abraham Katana; John Williamson; Feiko O ter Kuile
Journal:  Lancet       Date:  2015-09-28       Impact factor: 79.321

3.  Higher Rates of Misdiagnosis in Pediatric Patients Versus Adults Hospitalized With Imported Malaria.

Authors:  Adam E Goldman-Yassen; Vidya K Mony; Paul M Arguin; Johanna P Daily
Journal:  Pediatr Emerg Care       Date:  2016-04       Impact factor: 1.454

Review 4.  Human infections and detection of Plasmodium knowlesi.

Authors:  Balbir Singh; Cyrus Daneshvar
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

5.  Delayed Hemolysis After Parenteral Artesunate Therapy for Severe Malaria in Two Returning Canadian Travelers.

Authors:  Marthe Charles; Jeffery M Patterson; Leyla Asadi; Stan Houston
Journal:  Am J Trop Med Hyg       Date:  2015-08-03       Impact factor: 2.345

6.  Spread of artemisinin resistance in Plasmodium falciparum malaria.

Authors:  Elizabeth A Ashley; Mehul Dhorda; Rick M Fairhurst; Chanaki Amaratunga; Parath Lim; Seila Suon; Sokunthea Sreng; Jennifer M Anderson; Sivanna Mao; Baramey Sam; Chantha Sopha; Char Meng Chuor; Chea Nguon; Siv Sovannaroth; Sasithon Pukrittayakamee; Podjanee Jittamala; Kesinee Chotivanich; Kitipumi Chutasmit; Chaiyaporn Suchatsoonthorn; Ratchadaporn Runcharoen; Tran Tinh Hien; Nguyen Thanh Thuy-Nhien; Ngo Viet Thanh; Nguyen Hoan Phu; Ye Htut; Kay-Thwe Han; Kyin Hla Aye; Olugbenga A Mokuolu; Rasaq R Olaosebikan; Olaleke O Folaranmi; Mayfong Mayxay; Maniphone Khanthavong; Bouasy Hongvanthong; Paul N Newton; Marie A Onyamboko; Caterina I Fanello; Antoinette K Tshefu; Neelima Mishra; Neena Valecha; Aung Pyae Phyo; Francois Nosten; Poravuth Yi; Rupam Tripura; Steffen Borrmann; Mahfudh Bashraheil; Judy Peshu; M Abul Faiz; Aniruddha Ghose; M Amir Hossain; Rasheda Samad; M Ridwanur Rahman; M Mahtabuddin Hasan; Akhterul Islam; Olivo Miotto; Roberto Amato; Bronwyn MacInnis; Jim Stalker; Dominic P Kwiatkowski; Zbynek Bozdech; Atthanee Jeeyapant; Phaik Yeong Cheah; Tharisara Sakulthaew; Jeremy Chalk; Benjamas Intharabut; Kamolrat Silamut; Sue J Lee; Benchawan Vihokhern; Chanon Kunasol; Mallika Imwong; Joel Tarning; Walter J Taylor; Shunmay Yeung; Charles J Woodrow; Jennifer A Flegg; Debashish Das; Jeffery Smith; Meera Venkatesan; Christopher V Plowe; Kasia Stepniewska; Philippe J Guerin; Arjen M Dondorp; Nicholas P Day; Nicholas J White
Journal:  N Engl J Med       Date:  2014-07-31       Impact factor: 91.245

Review 7.  Review of mass drug administration for malaria and its operational challenges.

Authors:  Gretchen Newby; Jimee Hwang; Kadiatou Koita; Ingrid Chen; Brian Greenwood; Lorenz von Seidlein; G Dennis Shanks; Laurence Slutsker; S Patrick Kachur; Jennifer Wegbreit; Matthew M Ippolito; Eugenie Poirot; Roly Gosling
Journal:  Am J Trop Med Hyg       Date:  2015-05-26       Impact factor: 2.345

Review 8.  Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.

Authors:  Senaka Rajapakse; Chaturaka Rodrigo; Sumadhya Deepika Fernando
Journal:  Cochrane Database Syst Rev       Date:  2015-04-29

9.  The changing risk of Plasmodium falciparum malaria infection in Africa: 2000-10: a spatial and temporal analysis of transmission intensity.

Authors:  Abdisalan M Noor; Damaris K Kinyoki; Clara W Mundia; Caroline W Kabaria; Jonesmus W Mutua; Victor A Alegana; Ibrahima Socé Fall; Robert W Snow
Journal:  Lancet       Date:  2014-02-20       Impact factor: 202.731

Review 10.  Tools and Strategies for Malaria Control and Elimination: What Do We Need to Achieve a Grand Convergence in Malaria?

Authors:  Janet Hemingway; Rima Shretta; Timothy N C Wells; David Bell; Abdoulaye A Djimdé; Nicole Achee; Gao Qi
Journal:  PLoS Biol       Date:  2016-03-02       Impact factor: 8.029

View more
  5 in total

1.  4-Arylthieno[2,3-b]pyridine-2-carboxamides Are a New Class of Antiplasmodial Agents.

Authors:  Sandra I Schweda; Arne Alder; Tim Gilberger; Conrad Kunick
Journal:  Molecules       Date:  2020-07-13       Impact factor: 4.411

2.  Modeling and resistant alleles explain the selectivity of antimalarial compound 49c towards apicomplexan aspartyl proteases.

Authors:  Budhaditya Mukherjee; Francesca Tessaro; Juha Vahokoski; Inari Kursula; Jean-Baptiste Marq; Leonardo Scapozza; Dominique Soldati-Favre
Journal:  EMBO J       Date:  2018-03-08       Impact factor: 11.598

3.  Level of circulating steroid hormones in malaria and cutaneous leishmaniasis: a case control study.

Authors:  Farideh Esfandiari; Bahador Sarkari; Habibollah Turki; Nasir Arefkhah; Najme Shakouri
Journal:  J Parasit Dis       Date:  2018-11-20

4.  Effect of artemisinin and neurectomy of pterygoid canal in ovalbumin-induced allergic rhinitis mouse model.

Authors:  Jian Li; Bin Wang; Yingying Luo; Yajie Bian; Ruipei Wang
Journal:  Allergy Asthma Clin Immunol       Date:  2018-06-11       Impact factor: 3.406

5.  Metabolism of primaquine in normal human volunteers: investigation of phase I and phase II metabolites from plasma and urine using ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry.

Authors:  Bharathi Avula; Babu L Tekwani; Narayan D Chaurasiya; Pius Fasinu; N P Dhammika Nanayakkara; H M T Bhandara Herath; Yan-Hong Wang; Ji-Yeong Bae; Shabana I Khan; Mahmoud A Elsohly; James D McChesney; Peter A Zimmerman; Ikhlas A Khan; Larry A Walker
Journal:  Malar J       Date:  2018-08-13       Impact factor: 2.979

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.